rfhg_65782.1

Basic information about the TSS

---

TSS ID: rfhg_65782.1 Species: human Chr: chr5		Start: 10250350 End: 10250352 Strand: +
Source datasets	PRJNA401781
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3676758,EH38E2356508)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC002971:-4 GeneID: 22948 HGNC/MGI_ID: HGNC:1618 UniProt_ID: Q9BU08 Nearer transcript ids and distances:

Gene_name: CCT5 Gene_symbol: CCT5 Gene_synonyms: KIAA0098 Gene_source: HGNC:1618

TATA-Box annotation

---

Distance to TSS:	71
Nearest PromoterID:	NM_012073
Entrez ID:	22948
Nearest Unigene:	Hs.1600
Nearest Refseq:	NM_012073
Nearest Ensembl:	ENSG00000150753
Gene Name:	CCT5
Gene Alias:	CCT-epsilon|CCTE|HEL-S-69|PNAS-102|TCP-1-epsilon
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.333333
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CCT5 p2@CCT5 p3@CCT5
Sample		p1@CCT5	p2@CCT5	p3@CCT5
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	273.50	26.88	4.48
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	276.16	25.29	4.65
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	311.54	31.64	5.40
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	249.91	20.58	3.74
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	262.54	30.82	4.27
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	260.87	23.64	5.81
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	341.64	37.26	9.37
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	322.64	32.94	7.51
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	294.50	34.62	7.05
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	239.39	26.08	5.22
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	223.54	28.70	4.85
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	206.12	16.67	2.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	37.24	1.61	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	43.00	0.90	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	35.79	0.88	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	30.93	1.76	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	38.66	1.09	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	35.01	0.42	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	45.32	0.53	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	36.86	3.16	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	41.57	1.87	1.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	45.23	1.38	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	44.21	2.71	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	47.81	1.94	2.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	45.41	2.06	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	35.77	0.63	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	35.71	3.85	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	48.80	2.83	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	33.60	1.29	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	47.41	2.71	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	43.54	3.98	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	41.03	1.37	1.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	37.99	1.90	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	67.30	3.13	3.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	41.70	2.43	2.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	48.10	1.92	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	46.19	2.04	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	51.78	2.01	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	47.54	4.59	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	47.29	3.60	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	49.17	3.06	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	56.95	3.66	2.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	40.07	3.16	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	41.26	1.92	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	42.36	2.61	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	45.37	2.56	2.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	39.34	4.56	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	40.53	4.47	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	41.41	3.11	1.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	40.04	2.02	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	31.77	1.84	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	40.69	2.22	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	559.69	0.00	41.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	44.36	2.84	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	49.04	2.98	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	192.96	8.39	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	70.72	6.89	2.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	45.05	4.21	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	37.90	3.53	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	56.58	4.71	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	40.19	1.41	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	40.38	2.80	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	58.91	1.59	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	42.13	1.36	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	30.54	0.97	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	33.01	1.42	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	695.05	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	560.72	0.00	23.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	58.99	0.98	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	54.55	2.48	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	53.95	1.88	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	57.63	1.99	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	58.16	1.24	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	53.20	1.83	2.14
Adipocyte - breast, donor1	11376-118A8	97.41	2.06	1.74
Adipocyte - breast, donor2	11327-117E4	84.06	4.49	1.12
Adipocyte - omental, donor1	11473-119C6	98.73	3.05	2.04
Adipocyte - omental, donor2	11474-119C7	79.23	3.74	0.75
Adipocyte - omental, donor3	11475-119C8	74.02	0.67	0.67
Adipocyte - perirenal, donor1	11476-119C9	73.37	3.19	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	40.68	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	144.97	4.06	3.16
Adipocyte - subcutaneous, donor3	11408-118E4	66.38	1.74	1.39
Adipocyte differentiation, day04, donor1	13019-139D4	115.58	2.93	2.74
Adipocyte differentiation, day04, donor2	13022-139D7	65.37	2.83	1.54
Adipocyte differentiation, day04, donor3	13025-139E1	89.49	3.35	1.67
Adipocyte differentiation, day04, donor4	13028-139E4	68.77	4.11	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	126.68	11.90	3.70
Adipocyte differentiation, day08, donor2	13023-139D8	73.91	4.20	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	61.32	4.27	3.20
Adipocyte differentiation, day08, donor4	13029-139E5	72.89	3.90	2.78
Adipocyte differentiation, day12, donor1	13021-139D6	71.95	6.24	2.08
Adipocyte differentiation, day12, donor2	13024-139D9	62.79	3.52	1.76
Adipocyte differentiation, day12, donor3	13027-139E3	54.00	4.58	1.64
Adipocyte differentiation, day12, donor4	13030-139E6	66.37	3.65	1.83
Alveolar Epithelial Cells, donor1	11510-119G7	76.02	4.20	2.21
Alveolar Epithelial Cells, donor2	11590-120G6	21.16	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	50.01	0.90	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	28.76	1.03	0.41
Anulus Pulposus Cell, donor1	11248-116E6	94.40	1.72	1.49
Anulus Pulposus Cell, donor2	11463-119B5	51.92	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	106.93	6.29	4.04
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	95.95	3.91	4.34
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	72.77	2.14	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	106.12	3.59	3.89
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	98.64	5.06	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	57.43	1.32	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	81.22	3.25	3.57
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	91.75	3.40	2.43
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	71.27	2.38	2.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	120.15	7.16	3.01
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	97.24	3.63	3.63
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	56.42	0.00	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	95.71	3.62	2.80
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	110.55	0.00	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	85.65	2.87	3.02
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	105.01	3.21	3.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	86.53	2.83	4.16
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	84.20	3.47	2.94
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	57.55	2.93	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	85.09	4.31	3.48
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	60.04	4.80	6.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	113.28	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	85.76	3.26	3.43
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	87.38	3.40	3.88
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	100.18	3.42	4.93
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	66.63	0.00	3.63
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	94.06	3.99	2.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	70.12	3.21	2.78
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	55.49	2.58	1.55
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	87.74	1.88	4.22
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	77.49	3.86	2.25
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	77.05	2.85	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	86.57	2.34	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	87.01	3.31	4.22
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	66.53	1.19	5.94
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	100.19	2.54	4.07
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	95.51	2.55	3.31
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	55.28	3.18	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	99.68	3.02	3.45
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	88.48	2.96	2.12
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	62.35	3.19	2.03
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	99.20	2.83	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	87.14	3.05	2.88
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	71.81	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	137.32	2.11	6.34
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	92.63	3.43	2.79
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	72.20	3.61	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	98.41	5.83	4.37
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	88.04	4.37	2.76
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	76.51	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	84.91	2.54	3.31
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	78.65	2.48	2.48
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	55.69	2.75	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	98.47	3.82	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	71.40	4.66	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	57.98	1.53	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	94.16	3.88	2.77
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	80.76	3.71	3.97
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	64.69	1.45	2.54
Astrocyte - cerebellum, donor1	11500-119F6	54.41	3.44	1.11
Astrocyte - cerebellum, donor2	11580-120F5	30.81	1.37	1.20
Astrocyte - cerebellum, donor3	11661-122F5	16.57	0.42	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	171.85	9.41	3.83
Astrocyte - cerebral cortex, donor2	11316-117D2	187.33	11.00	7.12
Astrocyte - cerebral cortex, donor3	11392-118C6	194.51	6.71	4.62
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	222.26	8.14	9.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	258.21	11.78	9.40
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	236.81	10.13	9.10
Basophils, donor1	12241-129G9	29.81	1.83	0.00
Basophils, donor2	12242-129H1	57.37	2.16	2.16
Basophils, donor3	12243-129H2	48.07	1.18	1.32
Bronchial Epithelial Cell, donor1	11511-119G8	28.89	1.08	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	13.72	0.46	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	64.56	21.52	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	98.54	5.02	3.14
Bronchial Epithelial Cell, donor5	11457-119A8	100.23	3.33	2.50
Bronchial Epithelial Cell, donor6	11461-119B3	92.58	2.99	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	87.63	4.50	1.26
Burkitt's lymphoma cell line:DAUDI	10422-106C8	246.30	9.69	5.56
Burkitt's lymphoma cell line:RAJI	10476-106I8	375.44	10.48	6.06
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	141.66	0.64	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	186.15	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	50.72	1.69	2.25
CD14+ Monocytes, donor2	11305-117B9	38.05	2.97	1.67
CD14+ Monocytes, donor3	11381-118B4	37.76	2.20	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	71.04	1.13	1.98
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	54.21	3.03	1.90
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	64.43	2.96	2.63
CD14+ monocytes - mock treated, donor1	11863-125A9	126.77	4.77	3.76
CD14+ monocytes - mock treated, donor2	11873-125C1	121.00	4.53	1.81
CD14+ monocytes - mock treated, donor3	11883-125D2	121.76	4.97	1.90
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	97.93	3.68	1.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	118.13	2.76	2.76
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	157.19	7.44	2.98
CD14+ monocytes - treated with BCG, donor1	11860-125A6	73.03	3.52	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	75.85	2.67	2.85
CD14+ monocytes - treated with BCG, donor3	11880-125C8	139.28	4.79	3.48
CD14+ monocytes - treated with Candida, donor1	11868-125B5	80.54	3.98	2.58
CD14+ monocytes - treated with Candida, donor2	11878-125C6	115.64	4.22	4.75
CD14+ monocytes - treated with Candida, donor3	11888-125D7	154.20	2.22	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	101.00	3.57	3.42
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	158.04	6.39	2.79
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	194.04	7.50	5.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	115.99	7.32	4.35
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	129.84	5.20	2.26
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	128.76	3.49	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	69.13	3.23	1.34
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	89.15	2.97	2.27
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	95.53	3.79	2.95
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	117.21	6.25	2.76
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	113.43	3.17	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	132.06	3.07	3.07
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	69.05	2.27	2.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	79.91	0.74	1.86
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	130.84	4.96	3.02
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	94.59	7.78	2.05
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	118.91	3.25	3.01
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	151.49	6.03	3.02
CD14+CD16+ Monocytes, donor1	11789-124B7	132.96	4.36	2.18
CD14+CD16+ Monocytes, donor2	11801-124D1	129.82	2.77	2.54
CD14+CD16+ Monocytes, donor3	11912-125G4	120.44	3.90	1.30
CD14+CD16- Monocytes, donor1	11788-124B6	109.78	4.05	2.96
CD14+CD16- Monocytes, donor2	11799-124C8	109.50	2.45	1.22
CD14+CD16- Monocytes, donor3	11910-125G2	115.28	2.45	1.56
CD14-CD16+ Monocytes, donor1	11790-124B8	124.78	5.10	2.55
CD14-CD16+ Monocytes, donor2	11800-124C9	141.84	5.49	3.51
CD14-CD16+ Monocytes, donor3	11911-125G3	163.17	6.53	3.16
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	97.55	2.03	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	105.76	2.71	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	95.27	4.14	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	128.46	2.13	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	121.15	2.68	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	106.69	2.81	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	93.34	3.92	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	122.60	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	29.59	1.64	3.29
CD19+ B Cells, donor2	11624-122B4	21.04	2.18	0.00
CD19+ B Cells, donor3	11705-123B4	21.71	1.01	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	280.82	14.14	13.74
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	196.95	8.39	8.39
CD34+ Progenitors, donor1	11545-120B6	28.11	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	47.75	0.56	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	167.21	6.39	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	179.26	2.71	4.51
CD4+ T Cells, donor1	11225-116C1	36.42	0.71	1.07
CD4+ T Cells, donor2	11306-117C1	28.78	0.61	1.22
CD4+ T Cells, donor3	11382-118B5	35.07	1.52	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	121.75	1.53	1.28
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	117.24	1.57	1.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	98.89	1.15	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	70.17	4.27	3.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	76.55	2.81	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	65.92	6.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	80.64	1.73	2.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	90.15	1.69	1.53
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	74.32	0.81	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	68.59	2.24	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	73.02	1.40	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	82.28	3.08	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	102.04	1.69	2.53
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	77.08	3.12	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	67.16	1.00	1.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	74.51	2.45	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	85.22	1.61	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	60.97	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	144.08	3.34	2.23
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	120.87	2.82	2.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	108.02	2.52	1.89
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	82.92	2.02	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	74.09	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	83.68	1.74	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	92.05	2.97	3.96
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	101.55	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	94.92	2.79	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	155.91	5.26	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	160.24	5.89	1.72
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	81.62	6.16	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	108.51	1.43	5.01
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	95.56	1.38	1.38
CD8+ T Cells, donor1	11226-116C2	44.53	2.62	0.33
CD8+ T Cells, donor2	11307-117C2	19.90	1.50	0.38
CD8+ T Cells, donor3	11383-118B6	33.08	1.77	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	95.43	6.42	2.06
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	105.68	5.75	1.44
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	96.85	6.57	2.74
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	163.62	7.51	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	95.99	4.80	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	99.37	6.14	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	132.33	7.17	2.82
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	127.92	7.90	2.37
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	116.32	6.80	1.64
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	139.17	6.64	3.02
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	115.33	2.32	2.91
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	127.89	7.46	1.87
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	78.80	4.38	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	83.34	6.38	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	43.26	5.22	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	105.17	8.64	2.16
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	104.16	6.33	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	85.79	4.71	1.65
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	138.80	11.09	3.17
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	131.64	10.15	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	127.27	6.41	1.92
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	126.98	8.41	1.91
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	122.57	5.91	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	111.95	7.56	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	77.89	4.01	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	76.24	2.80	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	80.14	3.01	1.00
Cardiac Myocyte, donor1	11525-119I4	18.28	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	92.89	4.45	1.48
Cardiac Myocyte, donor3	11686-122I3	137.43	5.89	3.47
Chondrocyte - de diff, donor1	11261-116G1	109.20	5.55	0.00
Chondrocyte - de diff, donor2	11338-117F6	88.49	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	64.40	1.59	1.14
Chondrocyte - re diff, donor2	11339-117F7	252.46	1.79	1.79
Chondrocyte - re diff, donor3	11411-118E7	40.84	1.21	1.62
Ciliary Epithelial Cells, donor1	11242-116D9	151.14	6.20	5.28
Ciliary Epithelial Cells, donor2	11323-117D9	120.56	3.85	4.49
Ciliary Epithelial Cells, donor3	11399-118D4	118.59	5.84	3.36
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	61.53	15.41	9.54
Corneal Epithelial Cells, donor1	11526-119I5	28.54	0.88	0.66
Corneal Epithelial Cells, donor2	11606-120I4	43.23	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	69.02	2.05	2.05
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	81.89	0.83	2.15
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	83.58	3.15	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	55.21	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	71.06	1.73	1.08
Dendritic Cells - plasmacytoid, donor1	11228-116C4	25.62	0.00	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	37.87	1.96	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	26.62	0.97	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	214.13	2.50	2.17
Endothelial Cells - Aortic, donor1	11263-116G3	97.40	1.17	4.11
Endothelial Cells - Aortic, donor2	11340-117F8	82.01	1.41	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	52.69	1.97	0.00
Endothelial Cells - Artery, donor1	11264-116G4	90.17	2.62	0.87
Endothelial Cells - Artery, donor2	11341-117F9	160.69	2.82	4.00
Endothelial Cells - Artery, donor3	11413-118E9	154.62	4.91	2.80
Endothelial Cells - Lymphatic, donor1	11236-116D3	107.72	1.55	1.11
Endothelial Cells - Lymphatic, donor2	11317-117D3	97.67	1.52	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	95.57	1.97	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	96.27	1.78	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	147.87	3.12	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	57.57	0.85	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	211.26	3.60	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	76.00	1.57	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	263.28	4.47	2.61
Endothelial Cells - Umbilical vein, donor2	11324-117E1	95.16	1.30	1.52
Endothelial Cells - Umbilical vein, donor3	11400-118D5	129.70	3.54	1.59
Endothelial Cells - Vein, donor1	11267-116G7	80.76	3.41	1.14
Endothelial Cells - Vein, donor2	11344-117G3	160.66	3.49	2.10
Endothelial Cells - Vein, donor3	11416-118F3	101.74	1.73	2.04
Eosinophils, donor1	12244-129H3	60.99	15.25	0.00
Eosinophils, donor2	12245-129H4	42.91	0.00	1.65
Eosinophils, donor3	12246-129H5	28.53	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	30.30	1.47	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	16.64	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	97.61	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	59.52	2.05	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	49.38	1.75	1.75
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	68.69	2.60	1.63
Fibroblast - Aortic Adventitial, donor1	11245-116E3	167.37	7.28	4.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	162.81	5.60	4.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	67.61	2.43	0.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	123.05	3.43	2.63
Fibroblast - Aortic Adventitial, donor3	11401-118D6	124.91	4.32	1.99
Fibroblast - Cardiac, donor1	11268-116G8	115.67	1.81	1.81
Fibroblast - Cardiac, donor2	11345-117G4	84.89	6.06	2.27
Fibroblast - Cardiac, donor3	11417-118F4	70.66	3.31	1.73
Fibroblast - Cardiac, donor4	11452-119A3	113.97	2.12	3.64
Fibroblast - Cardiac, donor5	11456-119A7	136.17	4.70	2.79
Fibroblast - Cardiac, donor6	11460-119B2	171.45	5.91	3.34
Fibroblast - Choroid Plexus, donor1	11492-119E7	51.72	2.81	0.80
Fibroblast - Choroid Plexus, donor2	11572-120E6	62.13	0.86	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	225.58	8.79	7.32
Fibroblast - Conjunctival, donor1	11531-120A1	62.27	3.69	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	78.36	2.04	0.17
Fibroblast - Dermal, donor1	11269-116G9	123.03	3.76	1.88
Fibroblast - Dermal, donor2	11346-117G5	208.95	8.49	4.25
Fibroblast - Dermal, donor3	11418-118F5	117.62	3.99	3.14
Fibroblast - Dermal, donor4	11450-119A1	232.08	11.19	4.41
Fibroblast - Dermal, donor5	11454-119A5	263.60	13.96	5.93
Fibroblast - Dermal, donor6	11458-119A9	311.37	14.94	7.80
Fibroblast - Gingival, donor1	11237-116D4	177.20	7.08	6.25
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	68.12	3.14	3.14
Fibroblast - Gingival, donor2	11318-117D4	225.09	7.25	5.80
Fibroblast - Gingival, donor3	11394-118C8	91.76	3.58	2.51
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	99.73	2.08	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	67.31	1.76	2.11
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	159.64	9.04	4.52
Fibroblast - Gingival, donor6 (control)	11922-125H5	155.65	5.41	2.98
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	22.23	1.06	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	102.52	5.70	4.39
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	140.03	6.82	4.77
Fibroblast - Gingival, donor8 (control)	11926-125H9	205.89	15.03	6.47
Fibroblast - Gingival, donor9 (control)	11927-125I1	49.45	0.88	1.32
Fibroblast - Lung, donor1	11270-116H1	89.72	4.08	1.36
Fibroblast - Lung, donor2	11347-117G6	146.23	2.98	2.98
Fibroblast - Lung, donor3	11419-118F6	142.45	4.01	4.64
Fibroblast - Lymphatic, donor1	11506-119G3	60.81	1.67	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	18.18	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	8.96	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	103.52	4.87	2.44
Fibroblast - Mammary, donor2	11620-122A9	27.96	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	35.74	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	273.31	12.61	9.31
Fibroblast - Periodontal Ligament, donor2	11319-117D5	256.19	10.47	7.58
Fibroblast - Periodontal Ligament, donor3	11395-118C9	227.04	11.02	8.26
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	103.04	2.67	1.53
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	105.30	5.40	4.05
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	86.05	3.94	1.86
Fibroblast - Pulmonary Artery, donor1	11250-116E8	232.23	8.62	9.06
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	54.86	3.66	1.02
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	46.11	0.00	2.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	90.93	3.95	5.14
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	202.22	8.14	2.18
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	74.42	2.84	1.78
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	124.36	2.96	1.77
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	187.13	7.52	2.71
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	140.23	4.43	3.02
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	157.41	4.81	0.76
Fibroblast - skin normal, donor1	11553-120C5	101.07	2.63	1.48
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	239.61	12.03	6.62
Fibroblast - skin normal, donor2	11561-120D4	172.29	6.13	2.31
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	212.78	6.95	2.12
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	81.19	3.48	2.49
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	120.35	2.39	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	140.90	4.60	1.97
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	204.95	7.35	2.02
Fibroblast - skin walker warburg, donor1	11554-120C6	214.22	8.94	4.05
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	106.32	3.76	1.73
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	2747.81	22.16	110.80
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	47.06	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	144.93	6.07	5.20
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	153.28	9.11	4.94
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	149.99	9.45	6.90
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	234.26	14.55	4.59
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	340.73	22.33	14.68
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	309.23	24.25	11.98
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	110.85	9.10	3.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	79.00	8.22	1.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	203.68	14.66	10.50
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	115.51	7.40	5.55
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	69.80	5.22	5.87
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	287.45	10.61	14.15
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	251.13	13.28	12.15
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	194.32	10.10	6.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	198.51	13.16	11.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	206.16	11.40	8.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	240.45	13.29	10.52
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	190.70	11.38	8.34
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	131.89	4.34	5.93
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	167.79	9.97	6.35
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	120.44	7.21	3.06
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	125.87	5.02	6.80
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	158.00	9.70	6.20
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	103.00	7.60	5.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	136.10	8.67	5.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	205.44	10.35	8.99
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	189.31	10.02	7.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	159.73	9.47	6.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	152.67	8.37	4.95
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	145.62	7.64	5.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	170.80	9.48	6.74
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	158.44	8.98	4.70
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	133.48	4.33	5.57
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	125.67	7.03	3.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	135.91	7.67	6.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	92.36	7.27	4.41
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	138.49	5.41	6.15
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	125.95	9.56	4.21
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	94.61	5.45	2.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	121.00	5.21	5.59
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	114.99	6.64	4.27
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	105.21	4.26	3.04
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	144.89	7.11	6.38
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	106.05	5.27	4.17
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	89.78	4.21	5.05
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	124.25	5.93	4.07
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	126.48	8.82	3.74
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	141.99	5.81	4.59
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	147.15	6.87	5.57
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	103.01	5.69	4.07
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	96.23	4.61	5.16
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	91.45	3.29	2.85
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	66.45	4.96	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	89.44	5.28	2.90
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	91.80	3.43	3.03
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	80.31	2.54	3.30
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	382.99	22.89	8.76
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	270.10	15.72	8.47
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	340.22	17.18	9.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	255.66	18.78	12.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	248.65	18.37	10.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	229.22	18.45	6.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	232.63	9.90	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	263.42	20.89	11.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	187.72	4.81	6.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	161.71	3.48	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	237.27	11.39	10.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	237.20	18.12	8.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	143.29	16.66	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	178.97	12.30	6.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	200.68	11.77	7.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	143.44	7.55	15.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	183.21	15.59	11.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	212.29	13.59	8.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	212.99	10.44	14.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	219.92	14.32	10.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	148.29	10.36	6.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	181.27	15.25	11.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	234.86	12.01	11.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	214.71	17.26	11.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	131.71	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	141.85	7.69	7.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	140.82	7.50	5.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	105.68	8.69	4.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	146.02	12.33	8.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	202.67	16.09	9.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	119.27	12.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	132.12	10.85	8.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	114.66	7.24	9.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	127.68	6.61	6.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	157.94	10.77	8.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	147.51	10.36	6.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	120.40	5.90	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	140.03	8.17	4.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	114.11	8.78	4.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	92.40	9.32	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	90.13	7.76	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	117.92	10.19	4.85
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	100.43	5.71	3.42
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	68.19	2.91	1.66
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	122.57	2.25	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	59.63	1.59	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	57.23	0.42	2.09
Hep-2 cells mock treated, biol_rep1	11898-125E8	822.27	38.87	15.55
Hep-2 cells mock treated, biol_rep2	11899-125E9	839.96	37.98	13.67
Hep-2 cells mock treated, biol_rep3	11900-125F1	863.15	44.14	16.38
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	814.13	38.04	15.41
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	833.64	41.48	13.54
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	818.72	44.78	14.21
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	797.29	35.87	15.07
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	751.56	36.03	13.04
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	790.68	34.28	16.98
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	27.98	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	19.04	0.43	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	111.04	7.93	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	31.74	1.06	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	19.62	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	189.87	4.55	2.80
Hepatocyte, donor1	11523-119I2	25.42	1.21	1.21
Hepatocyte, donor2	11603-120I1	64.64	5.39	2.15
Hepatocyte, donor3	11684-122I1	48.47	0.61	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	171.66	6.53	5.22
Intestinal epithelial cells (polarized), donor1	11246-116E4	187.02	14.51	6.82
Iris Pigment Epithelial Cells, donor1	11530-119I9	143.11	7.13	4.94
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	181.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	166.88	26.70	13.35
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	243.75	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	150.90	5.54	6.92
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	135.14	7.51	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	249.23	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	169.15	5.13	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	155.41	4.57	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	224.16	14.62	17.87
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	205.08	18.34	5.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	192.42	3.63	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	248.81	11.91	13.23
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	200.66	14.41	6.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	188.58	5.24	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	245.02	13.86	10.08
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	193.33	15.47	7.73
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	102.44	14.63	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	247.43	18.74	14.21
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	186.75	11.27	6.44
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	191.17	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	250.17	8.96	10.59
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	210.74	10.92	9.24
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	143.72	14.37	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	262.81	8.84	12.06
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	204.05	7.39	9.23
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	150.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	249.24	7.55	11.80
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	207.70	11.79	11.79
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	191.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	263.65	9.69	10.76
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	227.41	15.25	8.89
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	180.73	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	267.19	10.84	7.01
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	154.93	5.47	7.29
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	212.08	10.71	11.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	195.78	3.32	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	104.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	264.83	12.96	9.57
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	154.53	5.27	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	144.58	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	173.85	9.74	6.95
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	126.15	4.43	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	188.04	16.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	147.36	6.10	7.85
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	139.49	6.75	6.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	121.96	0.00	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	146.15	6.40	11.73
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	163.48	12.47	4.16
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	116.83	5.70	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	141.75	6.44	7.36
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	105.89	3.03	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	117.96	0.00	12.42
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	101.51	3.17	5.29
Keratinocyte - epidermal, donor1	11272-116H3	133.17	8.08	3.10
Keratinocyte - epidermal, donor2	11349-117G8	131.18	6.44	2.93
Keratinocyte - epidermal, donor3	11421-118F8	187.99	7.57	5.68
Keratinocyte - oral, donor1	11251-116E9	218.86	5.56	5.34
Keratocytes, donor1	11527-119I6	35.76	2.75	1.03
Keratocytes, donor2	11607-120I5	37.50	1.17	0.00
Keratocytes, donor3	11688-122I5	78.05	3.95	2.96
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	4.40	2.20
Lens Epithelial Cells, donor1	11529-119I8	165.05	3.24	7.55
Lens Epithelial Cells, donor2	11609-120I7	122.25	2.77	1.61
Lens Epithelial Cells, donor3	11690-122I7	132.09	2.62	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	119.29	1.78	1.07
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	93.21	1.40	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	128.45	1.89	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	81.73	3.76	2.69
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	73.75	0.63	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	90.78	0.65	0.75
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	88.23	0.41	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	67.00	0.76	1.77
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	86.00	0.14	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	88.20	1.58	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	113.81	2.13	1.55
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	59.62	0.56	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	82.23	1.74	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	107.10	0.95	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	77.74	0.55	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	94.54	0.62	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	80.12	0.94	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	90.21	0.37	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	87.21	1.32	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	78.78	1.46	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	59.74	0.50	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	94.08	0.97	1.94
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	109.07	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	112.78	1.36	1.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	79.84	2.59	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	121.03	1.26	1.47
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	91.28	1.05	0.90
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	86.67	1.38	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	104.05	0.94	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	79.10	0.74	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	78.99	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	92.29	1.65	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	80.78	0.50	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	102.18	1.85	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	115.39	0.99	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	79.88	1.24	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	81.37	0.32	1.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	117.78	1.83	1.83
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	110.57	1.68	1.26
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	94.58	1.42	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	83.38	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	59.91	1.24	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	81.65	2.15	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	101.60	0.65	1.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	53.91	0.71	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	124.74	2.23	0.74
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	69.92	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	72.50	0.90	1.79
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	140.49	11.33	6.80
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	124.28	6.14	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	117.27	6.68	3.71
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	117.63	6.77	3.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	107.61	2.81	5.63
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	93.40	7.47	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	129.33	6.70	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	158.20	8.33	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	150.87	8.37	3.85
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	152.10	7.85	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	155.31	9.00	3.15
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	163.53	8.67	4.88
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	119.65	4.62	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	153.14	10.94	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	147.92	8.00	3.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	132.44	6.11	4.58
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	178.23	7.74	2.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	183.47	10.39	5.29
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	134.37	9.20	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	143.51	8.15	5.71
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	168.05	8.33	5.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	162.83	10.37	2.52
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	125.70	9.27	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	171.57	9.29	2.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	148.87	8.67	3.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	165.98	13.83	2.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	134.33	6.72	4.60
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	155.99	10.33	3.32
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	178.45	8.06	3.45
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	158.11	8.44	2.69
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	140.97	6.23	5.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	118.97	8.20	4.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	115.68	9.49	4.52
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	132.14	3.59	6.46
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	165.81	8.96	4.48
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	136.37	9.29	4.46
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	148.18	6.03	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	160.13	10.28	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	164.59	11.99	4.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	141.17	9.65	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	135.80	9.24	4.98
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	159.83	9.28	5.16
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	135.26	7.51	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	140.73	4.71	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	161.87	11.85	4.44
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	150.02	8.14	3.49
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	115.29	9.52	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	142.05	7.60	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	93.77	6.54	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	129.54	4.60	3.83
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	140.09	7.89	2.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	102.56	3.76	3.76
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	135.76	7.04	5.53
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	126.63	7.66	3.15
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	129.08	5.16	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	144.29	7.57	5.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	123.96	10.56	3.91
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	124.03	5.94	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	144.26	12.45	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	147.90	8.75	3.06
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	139.78	5.59	2.80
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	140.00	12.81	7.07
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	162.00	8.49	4.24
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	121.53	10.13	2.53
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	155.24	6.73	3.84
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	149.48	9.14	6.36
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	128.21	7.29	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	134.19	13.83	4.84
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	150.10	8.74	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	135.30	5.68	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	122.14	6.65	3.02
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	163.20	7.92	4.12
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	116.21	6.93	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	132.75	6.32	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	133.70	9.77	4.63
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	131.57	4.95	2.83
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	144.71	6.24	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	137.29	7.90	4.99
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	133.90	4.70	3.13
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	155.33	12.53	2.51
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	145.90	14.40	3.25
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	127.12	6.69	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	182.85	13.90	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	159.62	9.29	2.83
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	136.75	4.59	3.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	184.05	11.56	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	171.53	9.69	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	145.71	9.97	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	205.19	10.40	2.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	171.94	17.82	4.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	236.04	16.12	3.64
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	188.99	12.60	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	174.60	8.31	2.08
Macrophage - monocyte derived, donor1	11232-116C8	74.53	2.96	1.60
Macrophage - monocyte derived, donor2	11313-117C8	102.58	4.77	3.85
Macrophage - monocyte derived, donor3	11389-118C3	94.12	3.54	1.97
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	188.51	13.28	6.37
Mallassez-derived cells, donor2	11929-125I3	169.70	6.34	3.80
Mallassez-derived cells, donor3	11930-125I4	245.03	14.32	7.23
Mammary Epithelial Cell, donor1	11273-116H4	226.79	5.08	2.79
Mammary Epithelial Cell, donor2	11350-117G9	247.57	8.69	2.32
Mammary Epithelial Cell, donor3	11422-118F9	127.21	4.49	3.99
Mast cell - stimulated, donor1	11487-119E2	162.03	2.71	2.03
Mast cell, donor1	11563-120D6	61.86	0.87	0.65
Mast cell, donor2	11565-120D8	29.42	0.59	0.89
Mast cell, donor3	11566-120D9	35.12	0.68	0.68
Mast cell, donor4	11567-120E1	32.27	0.35	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	104.79	1.11	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	71.79	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	90.40	0.80	1.26
Mast cell, expanded, donor8	11941-126A6	42.85	0.33	0.50
Melanocyte - dark, donor1	11502-119F8	197.11	2.09	1.49
Melanocyte - dark, donor2	11582-120F7	86.17	2.77	1.38
Melanocyte - dark, donor3	11663-122F7	207.11	7.90	6.16
Melanocyte - light, donor1	11274-116H5	81.57	1.65	1.18
Melanocyte - light, donor2	11351-117H1	63.47	0.00	0.68
Melanocyte - light, donor3	11423-118G1	66.78	4.34	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	215.02	8.75	5.52
Melanocyte, donor2 (MC+2)	12739-135I3	127.48	6.45	3.77
Melanocyte, donor3 (MC+3)	12837-137B2	95.89	2.68	3.48
Meningeal Cells, donor1	11493-119E8	134.36	4.96	2.48
Meningeal Cells, donor2	11573-120E7	104.31	5.72	0.44
Meningeal Cells, donor3	11654-122E7	327.96	14.91	8.07
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	207.02	5.99	7.70
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	70.34	2.62	3.02
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	11.83	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	26.16	1.31	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	161.46	3.59	7.89
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	89.37	1.69	1.48
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	101.03	3.52	3.52
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	70.10	3.30	1.10
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	73.06	1.46	2.19
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	49.72	1.23	1.23
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	76.18	2.22	1.39
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	21.19	0.74	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	85.39	3.42	2.63
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	24.93	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	39.06	1.28	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	292.77	9.57	7.80
Mesenchymal stem cells - hepatic, donor0	11218-116B3	93.82	3.75	2.81
Mesenchymal stem cells - umbilical, donor0	11214-116A8	232.95	6.53	5.08
Mesothelial Cells, donor1	11247-116E5	98.38	5.30	3.18
Mesothelial Cells, donor2	12156-128G5	78.07	3.50	3.00
Mesothelial Cells, donor3	11402-118D7	62.36	4.62	2.02
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	16.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	53.93	2.46	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	55.95	2.94	2.06
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	46.18	1.86	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	48.75	1.87	4.15
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	54.81	2.25	1.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	37.24	2.33	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	54.46	2.24	2.44
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	45.14	2.38	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	41.59	1.77	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	73.33	3.80	4.56
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	54.97	1.70	1.70
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	7.37	0.92	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	39.05	1.49	2.09
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	52.44	3.26	1.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	50.62	0.95	1.43
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.21	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	60.09	1.38	1.38
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	54.48	3.37	2.10
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	37.30	1.63	1.22
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	52.99	2.36	1.29
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	38.90	0.67	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	44.46	1.97	1.10
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	20.28	1.01	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	42.94	1.63	1.09
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	35.58	2.06	2.94
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	54.78	2.88	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	42.02	3.20	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	62.07	3.50	3.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	60.00	0.88	2.19
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.76	0.64	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	63.72	4.71	1.98
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	13.22	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	68.38	1.71	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	16.19	0.88	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	10.30	0.71	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	62.28	2.24	1.68
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	18.70	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	48.87	1.81	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	57.60	0.83	2.09
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	29.55	0.92	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	52.93	2.85	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	31.37	1.66	1.52
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	55.98	1.81	1.81
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	35.61	1.72	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	2.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	25.09	1.60	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	53.28	3.89	1.50
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	26.84	1.55	0.85
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	62.43	1.91	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	45.55	2.21	1.33
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	9.86	0.76	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	60.51	3.13	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	62.68	3.20	1.97
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	37.64	0.00	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	57.95	3.46	1.73
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	41.21	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	27.40	2.08	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	82.87	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	40.99	1.78	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	72.29	2.30	1.97
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	71.53	5.26	4.21
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	52.98	1.19	1.58
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	44.70	0.93	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	59.71	1.88	1.88
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	53.27	3.20	2.40
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	82.90	2.60	2.38
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	43.47	3.68	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	53.13	2.20	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	85.56	0.00	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	81.23	2.14	3.74
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	57.57	2.02	3.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	63.67	1.26	2.11
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	47.67	1.36	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	38.78	0.64	2.54
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	42.11	4.05	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	37.76	0.00	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	57.10	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	97.87	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	57.03	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	169.12	5.39	3.23
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	78.91	3.66	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	40.72	2.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	27.96	1.25	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	115.61	3.61	2.47
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	76.60	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	16.32	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	305.05	12.86	16.54
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	20.51	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	59.50	2.79	1.86
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	22.70	0.81	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	53.82	1.68	1.47
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	501.06	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	38.22	1.49	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	36.00	0.54	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	31.74	1.13	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	22.86	0.49	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	55.95	2.73	3.28
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	23.34	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	15.01	1.80	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	56.77	2.95	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	18.86	1.30	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	52.56	3.17	2.47
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	26.72	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	14.71	1.38	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	23.14	0.96	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	69.32	2.76	3.10
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	184.58	2.53	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	34.75	0.67	2.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	16.51	1.27	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	22.55	0.95	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	27.47	2.15	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	586.80	18.06	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	24.99	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	22.54	2.25	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	30.16	2.38	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	26.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	29.13	0.76	2.27
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	20.53	0.00	1.63
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	9.15	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	33.47	0.90	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	27.34	3.53	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	19.95	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	22.32	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	13.78	0.77	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	50.21	2.12	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	43.54	2.21	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	33.88	2.03	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	178.83	15.33	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	22.56	3.05	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	12.59	0.94	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	16.34	0.61	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	20.57	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	34.01	2.27	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	263.01	15.17	15.17
Myoblast, donor1	11241-116D8	137.15	6.21	2.36
Myoblast, donor2	11322-117D8	102.80	3.45	3.07
Myoblast, donor3	11398-118D3	145.80	6.89	3.36
NK T cell leukemia cell line:KHYG-1	10777-110G3	162.13	5.98	3.50
Natural Killer Cells, donor1	11230-116C6	40.28	2.15	2.46
Natural Killer Cells, donor2	11311-117C6	27.44	1.21	0.60
Natural Killer Cells, donor3	11387-118C1	33.13	1.47	2.21
Neural stem cells, donor1	11275-116H6	173.12	6.17	5.81
Neural stem cells, donor2	11352-117H2	163.68	9.63	1.93
Neurons, donor1	11494-119E9	204.82	6.83	3.41
Neurons, donor2	11574-120E8	183.84	5.94	5.50
Neurons, donor3	11655-122E8	186.63	13.98	4.93
Neutrophils, donor1	11233-116C9	49.18	0.00	0.00
Neutrophils, donor2	11314-117C9	40.58	0.00	0.00
Neutrophils, donor3	11390-118C4	70.86	4.28	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	83.11	1.78	1.78
Nucleus Pulposus Cell, donor2	11409-118E5	38.42	0.00	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	101.48	2.81	1.60
Olfactory epithelial cells, donor1	11933-125I7	45.43	3.17	2.48
Olfactory epithelial cells, donor2	11934-125I8	89.16	2.46	3.47
Olfactory epithelial cells, donor3	11935-125I9	57.55	2.27	1.70
Olfactory epithelial cells, donor4	11936-126A1	59.70	3.21	1.46
Oligodendrocyte - precursors, donor1	11496-119F2	198.00	8.43	10.83
Osteoblast - differentiated, donor1	11276-116H7	68.70	2.13	0.85
Osteoblast - differentiated, donor2	11353-117H3	25.15	1.14	1.14
Osteoblast - differentiated, donor3	11425-118G3	35.38	0.62	1.86
Osteoblast, donor1	11277-116H8	169.25	3.52	2.54
Osteoblast, donor2	11354-117H4	224.04	4.21	1.40
Osteoblast, donor3	11426-118G4	109.66	5.87	3.02
Pancreatic stromal cells, donor1	11249-116E7	128.80	6.15	4.89
Pericytes, donor1	11491-119E6	14.80	0.45	0.00
Pericytes, donor2	11571-120E5	15.62	0.91	0.00
Pericytes, donor3	11652-122E5	32.76	1.63	1.63
Perineurial Cells, donor1	11499-119F5	190.55	8.36	4.07
Perineurial Cells, donor2	11579-120F4	134.52	4.23	5.06
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	56.42	1.59	1.91
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	35.51	1.47	1.71
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	41.02	1.42	1.81
Placental Epithelial Cells, donor1	11278-116H9	100.69	9.81	1.91
Placental Epithelial Cells, donor2	11355-117H5	67.64	4.44	0.00
Placental Epithelial Cells, donor3	11427-118G5	58.51	2.36	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	56.64	1.27	0.63
Preadipocyte - breast, donor1	11467-119B9	72.03	3.00	1.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	173.21	8.09	4.44
Preadipocyte - breast, donor2	11328-117E5	83.98	2.93	2.48
Preadipocyte - omental, donor1	11468-119C1	98.99	4.69	1.60
Preadipocyte - omental, donor2	11329-117E6	88.60	2.62	1.75
Preadipocyte - omental, donor3	11403-118D8	96.55	4.01	2.29
Preadipocyte - perirenal, donor1	11469-119C2	59.06	2.95	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	120.39	5.22	4.30
Preadipocyte - subcutaneous, donor2	11356-117H6	221.35	9.74	9.56
Preadipocyte - subcutaneous, donor3	11428-118G6	135.72	6.13	3.75
Preadipocyte - visceral, donor1	11280-116I2	241.34	10.62	6.52
Preadipocyte - visceral, donor2	11357-117H7	148.18	1.84	4.14
Preadipocyte - visceral, donor3	11429-118G7	173.66	7.11	3.87
Prostate Epithelial Cells (polarized), donor1	11253-116F2	227.79	25.80	10.11
Prostate Epithelial Cells, donor2	11331-117E8	77.19	3.79	2.30
Prostate Epithelial Cells, donor3	11404-118D9	47.83	3.18	0.92
Prostate Stromal Cells, donor1	11254-116F3	215.50	10.14	4.90
Prostate Stromal Cells, donor2	11332-117E9	145.95	6.81	5.38
Prostate Stromal Cells, donor3	11405-118E1	64.03	1.98	1.67
Renal Cortical Epithelial Cells, donor1	11516-119H4	50.00	1.82	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	182.08	9.70	4.09
Renal Epithelial Cells, donor1	11517-119H5	35.00	2.03	0.51
Renal Epithelial Cells, donor2	11597-120H4	41.97	2.13	1.42
Renal Epithelial Cells, donor3	11678-122H4	201.57	5.61	2.65
Renal Glomerular Endothelial Cells, donor1	11514-119H2	15.66	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	51.61	2.02	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	168.28	7.55	4.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	11.31	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	51.72	1.32	1.76
Renal Mesangial Cells, donor2	11598-120H5	30.10	1.25	1.88
Renal Mesangial Cells, donor3	11679-122H5	12.21	0.83	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	119.98	5.64	2.68
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	49.34	2.53	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	51.49	2.31	1.74
Retinal Pigment Epithelial Cells, donor0	11215-116A9	235.69	12.45	7.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	55.14	1.42	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	42.19	6.17	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	118.43	3.51	2.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	99.29	5.21	1.87
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	68.79	2.68	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	225.65	13.76	3.30
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	148.49	8.70	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	176.18	10.66	3.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	140.32	8.44	5.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	232.89	13.72	7.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	313.33	15.75	10.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	184.84	10.96	7.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	210.56	12.25	9.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	134.58	8.76	3.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	170.33	8.47	8.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	174.71	11.29	7.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	170.43	9.04	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	169.56	10.19	7.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	193.17	9.51	8.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	130.38	5.74	2.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	134.15	8.29	5.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	203.32	11.46	7.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	108.16	6.50	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	143.68	9.05	5.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	192.49	12.22	5.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	133.71	9.08	3.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	137.35	7.57	5.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	154.66	12.30	6.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	94.45	5.47	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	143.23	9.81	6.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	197.99	11.42	7.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	214.41	13.68	2.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	164.29	10.12	4.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	176.79	11.69	7.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	177.08	11.40	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	161.48	9.73	5.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	155.83	10.44	6.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	165.67	11.71	4.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	107.46	5.96	3.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	162.14	11.18	6.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	192.23	11.18	3.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	101.09	6.17	4.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	180.26	12.48	5.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	117.09	6.99	2.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	189.24	12.28	7.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	137.54	7.73	8.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	105.77	4.98	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	156.43	10.00	5.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	139.87	9.07	6.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	124.59	6.87	2.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	134.50	4.54	4.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	84.02	6.04	3.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	136.46	6.49	3.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	162.73	5.68	4.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	135.68	5.48	6.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	136.53	7.23	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	106.53	6.79	2.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	108.13	6.29	3.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	138.38	5.55	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	97.97	4.06	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	93.15	6.61	3.00
Schwann Cells, donor1	11498-119F4	56.99	2.26	1.50
Schwann Cells, donor2	11578-120F3	279.00	10.21	10.21
Schwann Cells, donor3	11659-122F3	177.67	5.48	2.85
Sebocyte, donor1	11220-116B5	209.80	12.05	4.93
Sebocyte, donor2	11301-117B5	141.54	3.68	2.30
Sebocyte, donor3	11378-118B1	68.64	3.09	2.27
Sertoli Cells, donor1	11255-116F4	117.62	4.97	3.31
Sertoli Cells, donor2	11333-117F1	81.91	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	130.74	4.05	2.64
Skeletal Muscle Cells, donor2	11358-117H8	25.30	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	108.68	8.36	1.67
Skeletal Muscle Cells, donor4	11451-119A2	207.99	10.21	4.40
Skeletal Muscle Cells, donor5	11455-119A6	180.90	8.03	4.61
Skeletal Muscle Cells, donor6	11459-119B1	275.64	13.54	6.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	157.26	4.54	3.02
Skeletal Muscle Satellite Cells, donor2	11321-117D7	103.31	3.85	3.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	217.96	10.71	8.04
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	141.46	4.55	1.85
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	104.95	5.79	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	73.89	2.06	0.55
Skin - palm, donor1	10286-104F7	26.86	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	55.50	2.88	1.59
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	134.95	4.09	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	67.38	1.69	0.91
Small Airway Epithelial Cells, donor1	11256-116F5	91.19	5.56	2.50
Small Airway Epithelial Cells, donor2	11334-117F2	67.23	3.38	1.97
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	188.19	5.50	4.44
Small Airway Epithelial Cells, donor3	11406-118E2	42.42	2.10	1.05
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	95.04	2.47	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	105.61	3.78	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	95.23	4.70	4.11
Smooth Muscle Cells - Aortic, donor1	11283-116I5	102.76	3.98	2.65
Smooth Muscle Cells - Aortic, donor2	11360-117I1	129.16	3.94	2.76
Smooth Muscle Cells - Aortic, donor3	11432-118H1	107.39	3.86	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	49.04	3.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	128.29	5.19	3.59
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	141.86	3.10	2.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	110.75	3.84	1.92
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	127.63	4.88	2.60
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	132.60	4.43	3.25
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	64.35	3.84	2.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	22.45	0.49	0.65
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	63.02	0.61	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	99.51	2.27	1.52
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	81.06	6.20	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	112.97	4.72	3.10
Smooth Muscle Cells - Colonic, donor2	11320-117D6	95.14	3.66	1.51
Smooth Muscle Cells - Colonic, donor3	11396-118D1	120.07	5.77	3.57
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	131.17	6.34	2.47
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	74.37	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	91.45	4.78	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	36.19	1.02	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	101.85	1.73	0.86
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	112.92	3.93	2.92
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	91.93	1.37	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	87.55	3.62	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	366.39	21.46	14.57
Smooth Muscle Cells - Prostate, donor1	11257-116F6	149.67	5.73	1.46
Smooth Muscle Cells - Prostate, donor2	11335-117F3	86.03	2.75	3.01
Smooth Muscle Cells - Prostate, donor3	11465-119B7	61.39	1.52	1.78
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	190.28	3.47	2.56
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	57.76	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	43.94	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	98.59	3.72	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	67.65	3.03	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	70.20	3.45	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	23.89	0.29	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	332.89	8.50	4.67
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	59.33	1.87	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	128.52	5.04	2.88
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	130.28	6.63	3.82
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	102.29	3.76	1.88
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	208.78	6.43	4.75
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	137.25	3.85	2.60
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	12.38	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	126.49	3.67	3.91
Smooth Muscle Cells - Uterine, donor1	11258-116F7	140.52	3.76	2.21
Smooth Muscle Cells - Uterine, donor3	11466-119B8	138.97	7.02	4.10
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	37.32	0.58	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	55.54	1.32	1.85
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	82.20	3.35	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	66.12	3.59	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	93.69	3.12	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	187.48	7.88	1.97
Smooth muscle cells - airway, control, donor1	11966-126D4	59.68	0.51	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	30.75	1.20	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	40.13	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	44.00	2.29	0.46
Synoviocyte, donor1	11291-117A4	96.62	3.20	1.85
Synoviocyte, donor2	11368-117I9	64.54	1.17	1.84
Synoviocyte, donor3	11440-118H9	49.60	1.12	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	73.25	3.57	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	31.71	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	42.14	1.62	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	150.90	6.38	3.30
Tracheal Epithelial Cells, donor2	11369-118A1	97.80	3.87	1.55
Tracheal Epithelial Cells, donor3	11441-118I1	109.95	1.72	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	103.59	4.92	3.08
Urethra, donor2	10319-105A4	26.98	0.00	0.00
Urothelial Cells, donor1	11520-119H8	30.29	0.80	0.53
Urothelial Cells, donor2	11600-120H7	28.04	0.40	0.40
Urothelial Cells, donor3	11681-122H7	15.36	0.69	0.69
Urothelial cells, donor0	11216-116B1	120.36	5.13	3.12
Whole blood (ribopure), donor090309, donation1	12179-129A1	121.90	1.78	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	108.65	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	44.49	0.68	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	75.75	4.48	2.41
Whole blood (ribopure), donor090325, donation2	12177-128I8	85.41	4.07	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	96.84	3.12	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	96.37	1.84	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	44.73	1.83	0.91
Wilms' tumor cell line:G-401	10809-111A8	158.03	9.62	3.82
Wilms' tumor cell line:HFWT	10597-108E3	51.04	4.40	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	353.06	27.65	10.61
achilles tendon, donor2	10292-104G4	90.93	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	345.47	9.69	5.35
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	392.84	10.22	7.43
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	171.53	12.70	6.65
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	408.44	9.80	8.44
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	357.54	11.24	6.75
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	190.33	2.33	2.11
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	165.78	3.54	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	274.96	11.90	6.61
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	133.13	2.45	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	174.73	3.49	3.88
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	483.92	20.06	11.22
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	152.12	3.90	11.70
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	226.34	3.95	3.25
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	319.74	5.44	7.51
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	292.24	5.26	3.80
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	194.27	6.51	2.32
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	167.79	6.99	2.88
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	58.32	3.38	1.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	398.97	26.88	12.37
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	346.36	21.84	12.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	371.65	23.35	11.55
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	529.90	24.06	10.91
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	205.13	6.00	5.34
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	156.09	7.43	7.43
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	280.61	10.17	4.52
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	131.71	2.62	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	86.23	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	112.80	3.53	4.71
adipose tissue, adult, pool1	10010-101C1	79.73	1.71	2.02
adipose, donor1	10184-103D4	266.23	9.97	7.62
adipose, donor2	10185-103D5	33.25	3.24	0.41
adipose, donor3	10186-103D6	86.32	4.63	5.17
adipose, donor4	10187-103D7	156.02	10.40	9.53
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	176.13	3.95	2.37
adrenal gland, adult, pool1	10081-102A9	40.01	10.91	7.28
adult T-cell leukemia cell line:ATN-1	10421-106C7	251.47	6.94	6.94
alveolar cell carcinoma cell line:SW 1573	10708-109H6	323.71	18.22	12.86
amniotic membrane cells, donor1	12235-129G3	76.51	2.78	1.16
amniotic membrane cells, donor2	12236-129G4	108.87	4.40	1.69
amniotic membrane cells, donor3	12237-129G5	55.97	2.95	0.88
amygdala - adult, donor10196	10167-103B5	90.12	11.86	1.19
amygdala, adult, donor10252	10151-102I7	49.27	1.82	2.03
amygdala, newborn, donor10223	10360-105E9	47.12	8.07	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	76.91	5.86	3.95
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	308.43	26.47	13.68
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	121.26	4.68	3.01
aorta, adult, pool1	10052-101G7	31.77	1.18	0.39
appendix, adult	10189-103D9	59.77	2.33	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	203.95	9.29	8.25
artery, adult	10190-103E1	28.53	4.08	0.00
astrocytoma cell line:TM-31	10425-106D2	209.77	6.95	5.79
b cell line:RPMI1788	10427-106D4	118.37	4.16	3.57
basal cell carcinoma cell line:TE 354.T	10702-109G9	106.82	5.83	2.77
bile duct carcinoma cell line:HuCCT1	10432-106D9	273.98	16.67	10.02
bile duct carcinoma cell line:TFK-1	10496-107C1	317.52	24.94	8.54
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	86.12	1.68	1.12
bladder, adult, pool1	10011-101C2	48.02	1.30	1.20
blood, adult, pool1	10053-101G8	53.15	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	83.92	1.71	1.71
bone marrow, adult	10192-103E3	65.46	2.02	0.67
brain, adult, donor1	10084-102B3	31.78	3.08	1.03
brain, adult, pool1	10012-101C3	57.68	2.34	2.00
brain, fetal, pool1	10085-102B4	64.11	8.01	5.34
breast carcinoma cell line:MCF7	10482-107A5	164.52	6.28	2.64
breast carcinoma cell line:MDA-MB-453	10419-106C5	138.18	4.74	2.62
breast, adult, donor1	10080-102A8	46.09	2.53	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	300.95	33.79	17.53
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	231.30	14.84	8.66
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	489.68	24.86	18.42
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	254.67	17.91	6.29
carcinoid cell line:NCI-H1770	10703-109H1	189.95	15.99	7.05
carcinoid cell line:NCI-H727	10735-110B6	81.05	4.59	2.52
carcinoid cell line:SK-PN-DW	10719-109I8	214.86	13.94	6.65
carcinosarcoma cell line:JHUCS-1	10642-109A3	210.55	19.96	14.11
caudate nucleus - adult, donor10196	10177-103C6	59.87	3.45	1.15
caudate nucleus, adult, donor10252	10164-103B2	64.09	5.19	2.01
caudate nucleus, adult, donor10258	10379-105H1	38.21	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	72.88	13.55	1.83
cerebellum - adult, donor10196	10173-103C2	34.96	2.91	2.91
cerebellum, adult, donor10252	10166-103B4	66.40	6.19	4.27
cerebellum, adult, pool1	10083-102B2	34.84	2.07	2.41
cerebellum, newborn, donor10223	10357-105E6	37.36	4.15	2.49
cerebral meninges, adult	10188-103D8	40.85	3.53	0.50
cerebrospinal fluid, donor2	10294-104G6	51.16	5.12	0.00
cervical cancer cell line:D98-AH2	10552-107I3	663.99	38.25	14.81
cervical cancer cell line:ME-180	10553-107I4	233.66	16.90	6.96
cervix, adult, pool1	10013-101C4	55.22	1.99	1.89
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	359.21	22.99	11.43
chondrosarcoma cell line:SW 1353	10700-109G7	22.21	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	326.47	28.21	12.05
choriocarcinoma cell line:SCH	10785-110H2	156.73	10.47	5.17
choriocarcinoma cell line:T3M-3	10618-108G6	103.88	8.78	3.56
chorionic membrane cells, donor1	12238-129G6	53.00	2.85	0.28
chorionic membrane cells, donor2	12239-129G7	131.85	5.47	3.38
chorionic membrane cells, donor3	12240-129G8	81.32	1.65	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	208.02	7.07	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	160.40	6.15	3.46
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	124.81	2.96	1.90
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	303.54	15.41	11.81
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	289.04	11.13	12.34
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	321.30	15.27	13.44
chronic myelogenous leukemia cell line:K562	10454-106G4	491.45	32.10	23.85
chronic myelogenous leukemia cell line:KU812	10409-106B4	228.05	2.87	1.56
clear cell carcinoma cell line:JHOC-5	10638-108I8	215.32	8.46	7.09
clear cell carcinoma cell line:TEN	10636-108I6	149.04	11.62	8.68
colon carcinoma cell line:CACO-2	10513-107D9	336.80	33.68	18.12
colon carcinoma cell line:COLO-320	10420-106C6	214.37	26.23	19.76
colon, adult, donor1	10082-102B1	38.08	4.76	2.38
colon, adult, pool1	10014-101C5	57.22	1.53	1.06
colon, fetal, donor1	10070-101I7	21.01	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	27.50	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	178.05	8.92	3.40
cord blood derived cell line:COBL-a 24h infection	10453-106G3	195.00	9.21	3.92
cord blood derived cell line:COBL-a untreated	10449-106F8	220.26	12.27	4.37
corpus callosum, adult, pool1	10042-101F6	75.96	3.54	1.99
cruciate ligament, donor2	10295-104G7	81.05	4.86	2.43
diaphragm, fetal, donor1	10069-101I6	29.69	1.61	1.61
diencephalon, adult	10193-103E4	48.24	3.36	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	197.47	5.28	4.13
ductal cell carcinoma cell line:KLM-1	10438-106E6	286.96	21.03	6.92
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	202.93	8.43	1.69
ductus deferens, adult	10196-103E7	39.37	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	38.89	4.32	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	72.09	5.89	0.00
dura mater, adult, donor1	10041-101F5	54.84	2.31	1.82
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	292.03	21.10	9.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	416.12	36.97	16.48
embryonic pancreas cell line:1B2C6	10604-108F1	77.69	1.23	4.93
embryonic pancreas cell line:1C3D3	10605-108F2	126.84	4.84	5.45
embryonic pancreas cell line:1C3IKEI	10606-108F3	116.40	5.56	2.16
embryonic pancreas cell line:2C6	10603-108E9	94.57	10.51	6.57
endometrial carcinoma cell line:OMC-2	10497-107C2	125.36	15.75	6.37
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	156.22	5.80	4.89
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	163.39	9.65	6.43
epidermoid carcinoma cell line:A431	10426-106D3	161.62	7.34	3.45
epidermoid carcinoma cell line:Ca Ski	10431-106D8	579.84	30.36	17.49
epididymis, adult	10197-103E8	33.91	1.67	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	240.92	16.85	7.45
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	114.43	7.47	4.33
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	678.05	44.16	19.40
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	481.47	28.15	12.89
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	674.64	44.48	19.05
esophagus, adult, pool1	10015-101C6	68.70	2.87	1.49
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	152.91	6.14	2.25
eye - muscle inferior rectus, donor1	10272-104E2	12.07	4.83	0.00
eye - muscle lateral, donor2	10298-104H1	25.25	4.21	0.00
eye - muscle medial, donor2	10299-104H2	10.42	1.49	0.00
eye - muscle superior, donor2	10297-104G9	43.57	3.44	0.00
eye - vitreous humor, donor1	10268-104D7	96.19	2.91	0.00
eye, fetal, donor1	10054-101G9	52.37	6.10	2.03
fibrosarcoma cell line:HT-1080	10758-110E2	307.61	12.57	5.90
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	338.56	29.20	12.11
frontal lobe, adult, pool1	10040-101F4	78.34	2.63	2.06
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	162.43	8.71	2.10
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	400.67	14.81	9.24
gall bladder, adult	10198-103E9	45.87	1.45	0.97
gamma delta positive T cells, donor1	11937-126A2	100.93	2.15	0.54
gamma delta positive T cells, donor2	11938-126A3	61.25	2.61	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	296.34	17.53	10.56
gastric adenocarcinoma cell line:MKN45	10612-108F9	218.17	17.02	10.64
gastric cancer cell line:AZ521	10549-107H9	268.39	14.76	11.80
gastric cancer cell line:GSS	10560-108A2	136.37	6.41	7.32
gastrointestinal carcinoma cell line:ECC12	10615-108G3	153.29	8.22	3.66
giant cell carcinoma cell line:LU65	10487-107B1	224.55	18.59	8.49
giant cell carcinoma cell line:Lu99B	10433-106E1	235.97	14.42	7.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	86.80	3.99	2.99
glioblastoma cell line:A172, tech_rep1	10444-106F3	154.42	10.98	4.96
glioblastoma cell line:A172, tech_rep2	10444-106F3	156.87	10.39	5.34
glioblastoma cell line:T98G	10485-107A8	214.68	10.93	6.73
glioma cell line:GI-1	10413-106B8	219.07	14.94	7.03
globus pallidus - adult, donor10196	10175-103C4	42.28	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	82.50	4.39	2.69
globus pallidus, adult, donor10258	10367-105F7	38.34	4.11	1.37
globus pallidus, newborn, donor10223	10364-105F4	42.63	6.40	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	51.39	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	47.04	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	64.32	3.20	3.52
hIPS +CCl2, biol_rep1	14383-156B9	251.14	18.36	7.80
hIPS +CCl2, biol_rep2	14384-156C1	259.27	7.77	1.83
hIPS +CCl2, biol_rep3	14385-156C2	267.30	11.59	1.93
hIPS, biol_rep1	14380-156B6	252.96	11.50	0.00
hIPS, biol_rep2	14381-156B7	245.54	13.03	0.69
hIPS, biol_rep3	14382-156B8	77.24	9.93	2.21
hairy cell leukemia cell line:Mo	10712-109I1	145.11	3.16	1.44
heart - mitral valve, adult	10205-103F7	36.77	1.79	0.30
heart - pulmonic valve, adult	10206-103F8	38.44	3.66	1.31
heart - tricuspid valve, adult	10207-103F9	47.46	4.16	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	74.68	5.92	4.69
heart, adult, diseased, donor1	10051-101G6	37.90	3.83	0.00
heart, adult, pool1	10016-101C7	52.43	0.92	0.92
heart, fetal, pool1	10046-101G1	90.97	5.24	1.64
hepatic mesenchymal tumor cell line:LI90	10778-110G4	51.21	1.54	2.47
hepatoblastoma cell line:HuH-6	10633-108I3	64.22	9.51	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	278.45	12.60	9.94
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	312.30	15.41	11.41
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	301.14	16.37	9.09
hepatoma cell line:Li-7	10484-107A7	422.62	26.47	14.68
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	299.59	13.67	6.33
hippocampus - adult, donor10196	10169-103B7	70.03	2.84	0.00
hippocampus, adult, donor10252	10153-102I9	54.90	3.47	1.63
hippocampus, adult, donor10258	10374-105G5	50.29	1.49	0.00
hippocampus, newborn, donor10223	10363-105F3	45.82	5.29	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	479.12	37.84	19.53
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	241.91	16.89	8.84
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	271.16	16.00	10.41
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	108.26	9.02	5.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	111.29	6.46	4.91
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	155.26	9.87	4.93
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	87.29	8.17	4.96
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	77.55	6.89	4.95
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	88.00	7.92	4.59
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	173.10	15.63	8.76
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	125.20	11.89	5.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	146.11	12.12	8.75
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	259.92	11.42	7.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	286.42	12.28	5.40
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	505.32	27.06	6.98
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	131.92	5.54	2.86
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	117.74	3.49	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	122.44	4.50	3.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	52.18	2.83	2.07
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	57.29	6.82	2.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	50.43	3.13	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	93.08	5.72	3.43
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	91.45	5.52	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	75.63	5.08	2.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	276.75	16.07	13.67
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	257.33	17.12	9.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	403.00	35.11	10.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	126.04	6.69	5.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	102.31	4.75	5.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	105.61	5.75	3.93
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	64.64	4.14	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	58.45	4.65	3.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	64.39	4.62	3.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	119.13	9.97	6.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	93.14	10.60	9.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	117.96	8.74	2.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	276.28	15.21	10.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	315.08	20.95	5.79
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	276.10	20.49	10.73
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	110.63	8.25	6.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	969.47	19.52	39.04
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	200.22	13.24	4.96
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	73.89	4.38	3.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	64.42	6.15	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	63.70	4.98	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	81.15	5.97	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	142.47	11.38	6.91
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	98.60	7.81	2.69
immature langerhans cells, donor1	11904-125F5	73.61	4.60	2.42
immature langerhans cells, donor2	11905-125F6	28.52	1.58	0.79
insula, adult, pool1	10039-101F3	91.70	3.31	2.18
keratoacanthoma cell line:HKA-1	10791-110H8	184.68	15.28	6.18
kidney, adult, pool1	10017-101C8	101.23	3.70	2.20
kidney, fetal, pool1	10045-101F9	68.97	4.31	1.77
large cell lung carcinoma cell line:IA-LM	10509-107D5	310.03	10.37	4.26
large cell lung carcinoma cell line:NCI-H460	10839-111E2	127.32	4.01	4.98
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	131.75	17.07	5.32
left atrium, adult, donor1	10079-102A7	32.15	2.18	0.00
left ventricle, adult, donor1	10078-102A6	37.42	2.53	0.51
leiomyoblastoma cell line:G-402	10721-110A1	133.52	7.66	3.28
leiomyoma cell line:10964C	10569-108B2	71.13	3.59	1.44
leiomyoma cell line:15242A	10570-108B3	76.09	3.80	1.09
leiomyoma cell line:15425	10571-108B4	111.94	3.89	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	101.59	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	95.15	5.23	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	210.85	3.66	2.72
liposarcoma cell line:KMLS-1	10782-110G8	72.17	4.69	1.56
liposarcoma cell line:SW 872	10726-110A6	207.25	18.89	11.33
liver, adult, pool1	10018-101C9	78.28	1.94	1.46
liver, fetal, pool1	10086-102B5	30.10	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	33.10	3.35	0.87
locus coeruleus, adult, donor10252	10165-103B3	74.37	5.54	1.48
locus coeruleus, adult, donor10258	10375-105G6	52.48	3.95	2.82
locus coeruleus, newborn, donor10223	10362-105F2	97.58	10.09	2.94
lung adenocarcinoma cell line:A549	10499-107C4	128.43	8.86	5.40
lung adenocarcinoma cell line:PC-14	10408-106B3	275.07	17.92	13.79
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	173.07	10.15	6.06
lung, adult, pool1	10019-101D1	52.33	2.48	1.30
lung, fetal, donor1	10068-101I5	112.74	3.42	1.14
lung, right lower lobe, adult, donor1	10075-102A3	46.74	2.29	0.00
lymph node, adult, donor1	10077-102A5	68.16	2.37	0.47
lymphangiectasia cell line:DS-1	10727-110A7	57.86	2.63	3.07
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	247.97	10.41	9.51
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	120.63	6.80	1.70
mature adipocyte, donor1	12231-129F8	39.07	1.78	0.44
mature adipocyte, donor2	12232-129F9	52.71	3.74	0.83
mature adipocyte, donor3	12233-129G1	50.26	2.13	2.13
mature adipocyte, donor4	12234-129G2	58.43	2.63	1.58
maxillary sinus tumor cell line:HSQ-89	10414-106B9	371.45	23.83	17.39
medial frontal gyrus - adult, donor10196	10170-103B8	93.63	4.51	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	50.57	3.49	2.21
medial frontal gyrus, adult, donor10258	10368-105F8	45.43	1.91	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	131.78	11.52	2.56
medial temporal gyrus - adult, donor10196	10183-103D3	74.42	3.21	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	56.45	2.97	1.70
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	32.75	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	387.55	14.35	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	58.51	6.10	1.08
medulla oblongata - adult, donor10196	10174-103C3	56.46	1.95	0.65
medulla oblongata, adult, donor10252	10155-103A2	69.66	3.25	1.86
medulla oblongata, adult, pool1	10038-101F2	63.91	5.47	1.47
medulla oblongata, newborn, donor10223	10361-105F1	51.73	7.64	1.74
medulloblastoma cell line:D283 Med	10838-111E1	251.08	11.96	6.86
medulloblastoma cell line:ONS-76	10759-110E3	334.42	23.35	13.82
melanoma cell line:COLO 679	10514-107E1	146.91	8.34	5.17
melanoma cell line:G-361	10465-106H6	197.35	9.23	5.70
meningioma cell line:HKBMM	10691-109F7	100.40	3.62	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	288.14	15.86	3.52
merkel cell carcinoma cell line:MS-1	10844-111E7	336.99	23.07	13.22
mesenchymal precursor cell - adipose, donor1	11747-123G1	159.11	4.45	3.99
mesenchymal precursor cell - adipose, donor2	11748-123G2	91.44	3.82	2.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	110.98	1.66	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	102.97	2.95	1.40
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	73.37	2.89	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	78.43	2.08	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	73.97	4.29	3.43
mesenchymal precursor cell - cardiac, donor2	11753-123G7	89.14	3.34	2.88
mesenchymal precursor cell - cardiac, donor3	11754-123G8	157.84	4.38	2.92
mesenchymal precursor cell - cardiac, donor4	11755-123G9	146.92	5.13	4.05
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	125.62	5.55	3.84
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	70.15	0.99	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	110.97	3.04	3.04
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	117.29	3.49	5.24
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	81.26	3.06	1.84
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	55.00	3.59	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	65.07	1.66	0.93
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	69.77	2.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	241.25	7.13	6.29
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	88.62	3.74	2.69
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	109.24	3.76	2.28
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	75.47	3.68	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	69.82	4.01	2.58
mesenchymal stem cell line:Hu5/E18	10568-108B1	182.72	11.79	6.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	83.11	4.11	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	91.83	1.79	1.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	83.24	2.36	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	79.18	2.77	2.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	83.08	3.53	1.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	74.12	5.75	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	81.35	2.75	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	82.95	1.85	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	100.95	4.61	2.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	80.99	2.45	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	77.87	3.12	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	99.00	2.20	3.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	79.55	2.69	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	93.75	1.64	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	81.19	5.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	101.17	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	72.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	90.94	2.27	1.95
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	78.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	78.90	0.53	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	60.52	1.64	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	68.80	3.11	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	67.16	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	78.48	0.99	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	57.21	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	77.09	1.78	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	70.67	1.22	4.87
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	79.81	5.70	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	51.39	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	49.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	47.90	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	51.66	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	46.04	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	42.90	0.79	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	48.34	1.18	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	55.80	1.56	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	60.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	68.59	1.18	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	92.45	2.57	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	77.79	4.13	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	92.03	5.94	1.98
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	85.23	7.85	4.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	96.68	9.54	2.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	77.37	6.04	2.82
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	85.04	10.90	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	73.49	8.87	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	67.36	6.68	3.03
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	117.49	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	42.01	0.82	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	80.56	3.57	1.98
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	65.55	1.95	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	52.97	4.07	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	32.50	3.09	3.09
mesothelioma cell line:ACC-MESO-1	10493-107B7	213.09	19.37	10.39
mesothelioma cell line:ACC-MESO-4	10494-107B8	110.04	9.73	3.24
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	290.60	4.27	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	250.61	9.97	7.40
mesothelioma cell line:Mero-25	10850-111F4	194.05	14.07	2.95
mesothelioma cell line:Mero-41	10851-111F5	161.11	11.98	5.13
mesothelioma cell line:Mero-48a	10852-111F6	178.69	8.64	5.09
mesothelioma cell line:Mero-82	10853-111F7	257.81	12.61	5.78
mesothelioma cell line:Mero-83	10854-111F8	151.84	6.64	2.55
mesothelioma cell line:Mero-84	10855-111F9	170.62	7.84	3.03
mesothelioma cell line:Mero-95	10856-111G1	251.76	10.35	4.76
mesothelioma cell line:NCI-H2052	10847-111F1	324.01	30.98	12.92
mesothelioma cell line:NCI-H226	10846-111E9	226.96	10.68	6.15
mesothelioma cell line:NCI-H2452	10848-111F2	195.93	8.20	4.61
mesothelioma cell line:NCI-H28	10845-111E8	158.53	9.92	4.07
mesothelioma cell line:No36	10857-111G2	254.44	15.98	5.55
mesothelioma cell line:ONE58	10858-111G3	167.72	8.13	3.25
migratory langerhans cells, donor1	11901-125F2	38.38	1.34	1.73
migratory langerhans cells, donor2	11902-125F3	40.66	1.95	1.83
migratory langerhans cells, donor3	11903-125F4	43.97	1.26	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	187.73	11.75	5.22
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	473.47	22.89	12.50
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	175.99	8.29	7.60
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	114.75	5.14	2.28
myelodysplastic syndrome cell line:SKM-1	10772-110F7	484.71	15.52	8.13
myeloma cell line:PCM6	10474-106I6	141.13	2.57	1.38
myxofibrosarcoma cell line:MFH-ino	10600-108E6	114.65	5.07	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	223.80	8.83	4.12
nasal epithelial cells, donor1, tech_rep1	12226-129F3	66.52	3.45	2.79
nasal epithelial cells, donor1, tech_rep2	12226-129F3	70.60	2.57	2.21
nasal epithelial cells, donor2	12227-129F4	89.42	3.31	4.97
neuroblastoma cell line:CHP-134	10508-107D4	248.24	14.72	4.83
neuroblastoma cell line:NB-1	10539-107G8	296.72	11.04	9.35
neuroblastoma cell line:NBsusSR	10607-108F4	185.37	13.50	7.59
neuroblastoma cell line:NH-12	10555-107I6	282.88	20.13	12.11
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	92.99	2.85	1.66
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	143.18	8.87	5.07
neuroectodermal tumor cell line:TASK1	10774-110F9	175.50	5.43	1.41
neuroepithelioma cell line:SK-N-MC	10728-110A8	147.50	8.90	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	92.36	2.66	1.06
neutrophil PMN, donor1	12133-128D9	44.62	14.87	0.00
neutrophil PMN, donor2	12137-128E4	106.25	0.00	0.00
neutrophil PMN, donor3	12141-128E8	75.77	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	359.21	5.58	2.88
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	249.76	6.40	3.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	74.70	3.85	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	69.90	1.84	2.10
nucleus accumbens, adult, pool1	10037-101F1	86.05	5.34	3.00
occipital cortex - adult, donor10196	10172-103C1	86.54	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	55.55	2.95	2.42
occipital cortex, newborn, donor10223	10355-105E4	44.04	4.37	0.73
occipital lobe, adult, donor1	10076-102A4	49.86	2.36	0.52
occipital lobe, fetal, donor1	10073-102A1	90.11	3.86	3.43
occipital pole, adult, pool1	10036-101E9	50.85	3.00	1.66
olfactory region, adult	10195-103E6	47.19	3.44	1.53
optic nerve, donor1	10277-104E7	16.01	6.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	160.95	8.54	5.01
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	778.57	93.83	38.06
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	159.67	7.45	5.42
oral squamous cell carcinoma cell line:SAS	10544-107H4	238.41	11.55	8.20
osteoclastoma cell line:Hs 706.T	10704-109H2	75.26	3.23	1.76
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	202.75	14.02	5.61
osteosarcoma cell line:HS-Os-1	10558-107I9	220.54	14.00	7.21
ovary, adult, pool1	10020-101D2	74.42	3.84	1.31
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	212.29	17.05	5.87
pancreas, adult, donor1	10049-101G4	67.73	2.82	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	163.53	10.90	7.55
papillary adenocarcinoma cell line:8505C	10437-106E5	345.14	16.69	11.58
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	133.13	6.95	5.13
paracentral gyrus, adult, pool1	10035-101E8	77.61	2.75	1.92
parietal cortex, adult, donor10258	10373-105G4	42.57	2.94	1.47
parietal lobe - adult, donor10196	10171-103B9	66.77	3.76	0.94
parietal lobe, adult, donor10252	10157-103A4	55.58	2.57	2.28
parietal lobe, adult, pool1	10034-101E7	82.39	2.82	2.11
parietal lobe, fetal, donor1	10072-101I9	87.29	5.82	4.85
parietal lobe, newborn, donor10223	10356-105E5	52.71	4.49	0.37
parotid gland, adult	10199-103F1	56.12	2.47	1.23
penis, adult	10200-103F2	49.41	1.61	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	127.37	6.88	3.35
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	278.57	15.44	6.85
pineal gland - adult, donor10196	10179-103C8	35.48	1.29	0.65
pineal gland, adult, donor10252	10160-103A7	113.70	4.74	4.15
pineal gland, adult, donor10258	10377-105G8	29.47	2.51	2.51
pituitary gland - adult, donor10196	10180-103C9	72.85	4.05	1.01
pituitary gland, adult, donor10252	10162-103A9	131.86	7.30	2.08
pituitary gland, adult, donor10258	10378-105G9	56.18	3.40	1.70
placenta, adult, pool1	10021-101D3	81.49	3.76	2.15
plasma cell leukemia cell line:ARH-77	10840-111E3	215.06	8.61	5.83
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	83.89	4.98	2.65
pons, adult, pool1	10033-101E6	89.68	5.51	3.10
postcentral gyrus, adult, pool1	10032-101E5	63.29	3.14	2.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	16.73	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	93.64	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	369.98	22.29	13.84
prostate cancer cell line:PC-3	10439-106E7	258.10	13.98	7.62
prostate, adult, pool1	10022-101D4	49.61	3.26	1.09
putamen, adult, donor10196	10176-103C5	96.08	3.07	0.94
putamen, adult, donor10252	10152-102I8	47.06	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	95.07	7.65	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	47.36	3.38	0.72
putamen, newborn, donor10223	10365-105F5	117.70	23.99	3.75
rectal cancer cell line:TT1TKB	10469-106I1	90.77	7.27	2.33
rectum, fetal, donor1	10067-101I4	33.38	1.39	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	133.13	6.57	4.03
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	41.42	0.83	0.83
retina, adult, pool1	10030-101E3	39.36	3.18	1.89
retinoblastoma cell line:Y79	10475-106I7	257.98	22.86	10.13
rhabdomyosarcoma cell line:KYM-1	10787-110H4	155.78	10.33	4.55
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	183.34	19.40	9.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	40.17	0.76	2.27
salivary acinar cells, donor1	11771-123I7	82.38	2.10	1.13
salivary acinar cells, donor2	11772-123I8	77.93	0.96	0.96
salivary acinar cells, donor3	11773-123I9	39.72	1.99	0.66
salivary gland, adult, pool1	10093-102C3	73.78	2.29	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	162.30	6.83	3.71
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	165.75	5.41	5.05
seminal vesicle, adult	10201-103F3	22.75	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	94.50	4.62	1.94
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	99.39	7.30	4.03
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	163.58	10.04	11.04
serous cystadenocarcinoma cell line:HTOA	10693-109F9	136.34	11.69	3.22
signet ring carcinoma cell line:Kato III	10436-106E4	139.26	4.86	3.21
signet ring carcinoma cell line:NUGC-4	10483-107A6	166.18	8.00	5.68
skeletal muscle - soleus muscle, donor1	10282-104F3	44.69	5.67	1.42
skeletal muscle, adult, pool1	10023-101D5	73.88	10.07	2.88
skeletal muscle, fetal, donor1	10066-101I3	68.34	3.02	1.01
skin, adult, donor1	10074-102A2	54.28	6.79	13.57
skin, fetal, donor1	10065-101I2	65.65	1.89	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	546.64	49.03	22.68
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	156.97	8.83	4.41
small cell lung carcinoma cell line:DMS 144	10841-111E4	268.30	25.06	15.81
small cell lung carcinoma cell line:LK-2	10541-107H1	536.68	27.36	15.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	284.06	16.25	7.56
small cell lung carcinoma cell line:WA-hT	10562-108A4	125.74	8.72	6.76
small intestine, adult, pool1	10024-101D6	81.22	4.06	2.03
small intestine, fetal, donor1	10064-101I1	62.41	3.93	2.95
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	258.50	13.85	8.72
smooth muscle, adult, pool1	10048-101G3	40.32	1.03	1.81
somatostatinoma cell line:QGP-1	10781-110G7	107.74	2.68	0.27
spinal cord - adult, donor10196	10181-103D1	41.29	2.29	0.92
spinal cord, adult, donor10252	10159-103A6	69.39	3.94	1.18
spinal cord, adult, donor10258	10369-105F9	42.20	2.77	0.00
spinal cord, fetal, donor1	10056-101H2	57.32	4.27	0.61
spinal cord, newborn, donor10223	10359-105E8	87.25	6.89	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	97.68	4.93	2.99
spleen, adult, pool1	10025-101D7	75.99	1.76	2.31
spleen, fetal, pool1	10044-101F8	85.02	1.99	1.91
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	120.07	5.59	3.11
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	105.76	4.18	2.66
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	124.75	8.74	5.94
squamous cell carcinoma cell line:T3M-5	10616-108G4	144.64	5.86	3.52
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	236.04	14.07	8.67
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	143.18	23.72	5.93
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	279.23	9.73	5.08
stomach, fetal, donor1	10062-101H8	29.90	3.20	1.07
submaxillary gland, adult	10202-103F4	57.54	3.99	1.14
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	81.84	2.70	1.66
substantia nigra, adult, donor10258	10371-105G2	55.86	4.14	0.52
substantia nigra, newborn, donor10223	10358-105E7	38.16	3.53	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	349.17	26.14	12.84
temporal lobe, adult, pool1	10031-101E4	61.54	2.63	1.44
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	62.68	4.27	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	74.28	4.40	0.44
tenocyte, donor1	11763-123H8	92.86	1.40	3.14
tenocyte, donor2	11765-123I1	42.73	1.53	1.53
tenocyte, donor3	11768-123I4	91.18	2.59	1.85
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	371.02	18.70	10.88
teratocarcinoma cell line:NCR-G1	10798-110I6	247.41	21.89	12.33
teratocarcinoma cell line:PA-1	10807-111A6	236.65	9.45	6.35
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	158.81	12.57	4.95
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	216.31	15.51	6.43
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	216.05	14.29	11.23
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	347.20	24.43	11.40
testis, adult, pool1	10026-101D8	124.02	44.45	23.94
testis, adult, pool2	10096-102C6	126.75	53.68	12.18
thalamus - adult, donor10196	10168-103B6	52.99	2.21	1.10
thalamus, adult, donor10252	10154-103A1	67.05	5.47	1.09
thalamus, adult, donor10258, tech_rep1	10370-105G1	56.97	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	19.93	1.32	0.66
thalamus, newborn, donor10223	10366-105F6	60.41	10.93	2.30
throat, adult	10209-103G2	62.17	2.25	1.75
throat, fetal, donor1	10061-101H7	50.28	2.44	2.74
thymic carcinoma cell line:Ty-82	10803-111A2	163.16	7.15	7.55
thymus, adult, pool1	10027-101D9	129.34	3.38	3.08
thymus, fetal, pool1	10043-101F7	95.07	2.91	1.25
thyroid carcinoma cell line:KHM-5M	10776-110G2	271.51	11.97	6.25
thyroid carcinoma cell line:TCO-1	10783-110G9	229.37	13.69	7.68
thyroid, adult, pool1	10028-101E1	110.20	6.07	3.55
thyroid, fetal, donor1	10060-101H6	41.92	1.58	2.11
tongue epidermis (fungiform papillae), donor1	10288-104F9	15.40	0.00	0.00
tongue, adult	10203-103F5	80.24	4.42	3.26
tongue, fetal, donor1	10059-101H5	83.15	3.55	1.18
tonsil, adult, pool1	10047-101G2	89.96	3.41	2.50
trachea, adult, pool1	10029-101E2	95.62	3.60	2.54
trachea, fetal, donor1	10058-101H4	44.24	2.31	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	138.17	7.79	2.48
transitional-cell carcinoma cell line:5637	10418-106C4	284.09	13.68	8.21
transitional-cell carcinoma cell line:JMSU1	10492-107B6	454.86	32.12	22.56
tridermal teratoma cell line:HGRT	10694-109G1	28.54	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	105.22	3.05	2.20
umbilical cord, fetal, donor1	10057-101H3	50.08	6.26	0.00
uterus, adult, pool1	10100-102D1	67.57	3.24	0.34
uterus, fetal, donor1	10055-101H1	81.40	0.51	0.51
vagina, adult	10204-103F6	83.36	10.99	1.29
vein, adult	10191-103E2	43.40	0.22	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	83.85	2.67	2.14